Authors: Paraskevas, Kosmas I.; Mikhailidis, Dimitri P.

Source: Current Medical Research and Opinion, Volume 24, Number 1, January 2008 , pp. 75-78(4)

Publisher: Informa Healthcare

Abstract:

This editorial discusses whether measuring C-reactive protein (CRP) levels can be used as a predictor of vascular risk. The agents that reduce CRP levels and the evidence for a possible causative role of CRP in the pathogenesis of coronary events and atherosclerosis are also considered. There is a need to further elucidate the role of CRP, as well as the clinical relevance, if any, of CRP-lowering agents.

Keywords: ATHEROSCLEROSIS; C-REACTIVE PROTEIN; INFLAMMATION; PROGNOSTIC MARKER

Document Type: Editorial

DOI: http://dx.doi.org/10.1185/030079908X253654

Affiliations: 1: Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital and Royal Free University College Medical School, University College London (University of London), London, UK

Publication date: 2008-01-01

More about this publication?

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• General Information
• Journal Information
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine (General)
• By this author: Paraskevas, Kosmas I. ;  Mikhailidis, Dimitri P.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers